Showing results (71-80 of 139) with videos related to
Sort By:
Pageof 14
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1992
MHC molecules protect T cell epitopes against proteolytic destructionS Mouritsen, M Meldal, O Werdelin, et al.Immunological Reviews|December 1, 1988
Facts on the fragmentation of antigens in presenting cells, on the association of antigen fragments with MHC molecules in cell-free systems, and speculation on the cell biology of antigen processingO Werdelin, S Mouritsen, B L Petersen, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1989
Structural analysis of peptides capable of binding to more than one Ia antigenA Sette, S Buus, S Colon, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1988
I-Ad-binding peptides derived from unrelated protein antigens share a common structural motifA Sette, S Buus, S Colon, et al.Immunologic Research|January 1, 1990
Structural requirements for the interaction between class II MHC molecules and peptide antigensA Sette, S Buus, E Appella, et al.The West Indian Medical Journal|December 13, 2007
Gender, acculturative stress and Caribbean immigrants' health in the United States of America: an exploratory studyI L Livingston, M Neita, L Riviere, et al.The Journal of Experimental Medicine|May 1, 1990
MHC class II-derived peptides can bind to class II molecules, including self molecules, and prevent antigen presentationE F Rosloniec, L J Vitez, S Buus, et al.Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|June 12, 1989
Structural requirements and biological significance of interactions between peptides and the major histocompatibility complexH M Grey, S Buus, S Colon, et al.Science (New York, N.Y.)|March 13, 1987
The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptidesS Buus, A Sette, S M Colon, et al.The Journal of Biological Chemistry|June 9, 2001
Role of the T cell receptor ligand affinity in T cell activation by bacterial superantigensP S Andersen, C Geisler, S Buus, et al.Pageof 14